Novo Nordisk A-S

Yahoo Finance • 8 hours ago

Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors

Key Points The market for GLP-1 drugs is large and attractive, with Eli Lilly currently an industry leader. Competition in the drug industry is fierce, with Eli Lilly already working on a more effective GLP-1 option. 10 stocks we like bet... Full story

Yahoo Finance • 10 hours ago

CVS Decision Tests Novo Nordisk Wegovy Edge And Valuation Story

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. CVS Caremark has granted preferred formulary status to both Novo N... Full story

Yahoo Finance • 13 hours ago

Stock Split Watch: Is Eli Lilly Next?

The market has been ripe with stock splits in recent times, with companies from tech giant Nvidia to fast-casual restaurant chain Chipotle Mexican Grill announcing them. This occurred after these stocks soared in recent years, in many case... Full story

Yahoo Finance • yesterday

Eli Lilly (LLY): Top Healthcare Stock Pick of Claude AI

We just covered the Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot. Eli Lilly and Company (NYSE:LLY) ranks #2 (see Claude Stock Portfolio: Top 5 Stocks to Buy According to AI Chatbot). Number of Hedge Funds: 137 Eli... Full story

Yahoo Finance • yesterday

Lilly Reopens Zepbound Access For 10 Million US Patients

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) is getting a major access win in the obesity drug market after CVS Health reversed its earlier restriction on Zepbound across certain drug plans. The decision could put more t... Full story

Yahoo Finance • yesterday

Eli Lilly's $1 trillion valuation cements its status as Wall Street's ultimate weight-loss play

Eli Lilly (LLY) is back above $1 trillion, closing at its first record high since November, as Wall Street starts pricing in a drug many investors may not know yet: Reta. The stock is up more than 25% since the market’s March 30 low and m... Full story

Yahoo Finance • 3 days ago

Novo Nordisk (NVO) Among Our Most Undervalued Foreign Stocks to Buy Now

Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued Foreign Stocks to Buy Now. On May 6, Reuters reported that Novo Nordisk A/S (NYSE:NVO) topped first-quarter profit forecasts and also raised the full-year outlook slightly. The re... Full story

Yahoo Finance • 3 days ago

Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion

Eli Lilly LLY has officially entered Wall Street history books as the first pharmaceutical company to reach a $1 trillion market capitalization. The pharmaceutical giant’s stock has surged to new record highs of over $1,000 a share, cemen... Full story

Yahoo Finance • 3 days ago

Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot

Hims & Hers Health shares have slumped in 2026 as the telehealth provider moves away from selling compounded GLP-1 medications. Continue Reading... Full story

Yahoo Finance • 3 days ago

Novo Nordisk advances cardiometabolic pipeline with new data featuring CagriSema and zenagamtide at the American Diabetes Association's 2026 Scientific Sessions

Phase 3 REIMAGINE 1–3 trial results across a range of type 2 diabetes patient groups offer further insight into CagriSema, a novel amylin RA and a GLP-1 RA in a fixed-dose combination1 Mid-stage trial data for investigational zenagamtide e... Full story

Yahoo Finance • 4 days ago

Egina Gold Project Update

HIGHLIGHTS Northern Star Resources Ltd (Northern Star) (ASX: NST) has informed Novo that they are withdrawing from the earn-in under the Egina Earn-In and Joint Venture AgreementAll data gathered by Northern Star’s exploration activities... Full story

Yahoo Finance • 4 days ago

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks were lower late Tuesday afternoon, with the NYSE Healthcare Index shedding 0.7% an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Novo Nordisk POSEIDON Data Highlights Residual Inflammatory Risk And New Opportunity

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Novo Nordisk (CPSE:NOVO B) reported new findings from its POSEIDON study on cardiovascular inflammation in patients wi... Full story

Yahoo Finance • 4 days ago

Sector Update: Healthcare Stocks Decline Tuesday Afternoon

Healthcare stocks were lower Tuesday afternoon, with the NYSE Healthcare Index shedding 0.6% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Ozempic, Other Weight Drug Users Cut Back On Eating Out. What That Means For Restaurants.

Weight-loss drugs such as Novo Nordisk's Ozempic and Wegovy are disrupting eating habits, and restaurants should prepare for changes, an analyst says. More than half of Americans taking GLP-1 drugs including Eli Lilly's Mounjaro have chang... Full story

Yahoo Finance • 4 days ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were trending higher late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S Bagsværd, Denmark, 26 May 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and... Full story

Yahoo Finance • 4 days ago

Novo Nordisk and Eli Lilly Just Delivered Potential Breakthrough for Cancer Patients

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) may have an additional growth story on their hands after a new set of studies suggested GLP-1 medicines could help cancer patients fare better, acc... Full story

Yahoo Finance • 4 days ago

If Viking Therapeutics Is Acquired, Here’s Who Wins

Quick Read Viking Therapeutics (VKTX) is the most closely watched biotech acquisition target. A buyer such as Eli Lilly (LLY) would benefit, as would Viking shareholders, and at least one GLP-1 competitor. The analyst who called NVIDIA in... Full story

Yahoo Finance • 4 days ago

Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®

MISSISSAUGA, ON, May 26, 2026 /CNW/ - Novo Nordisk Canada is announcing that effective Friday, May 29, 2026, eligible Canadians who do not have public or private coverage and choose the brand Ozempic® (semaglutide injection) will pay less,... Full story